| Attribute |
Value |
| 52 Week Change |
0.12324929 |
| Address1 |
Wagistrasse 14 |
| All Time High |
32.04 |
| All Time Low |
3.32 |
| Ask |
4.01 |
| Ask Size |
1 |
| Average Analyst Rating |
1.4 - Strong Buy |
| Average Daily Volume10 Day |
10,560 |
| Average Daily Volume3 Month |
6,486 |
| Average Volume |
6,486 |
| Average Volume10Days |
10,560 |
| Beta |
0.673 |
| Bid |
3.91 |
| Bid Size |
1 |
| Book Value |
2.2580907 |
| City |
Schlieren |
| Compensation As Of Epoch Date |
1,767,139,200 |
| Country |
Switzerland |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
4.0099 |
| Current Ratio |
9.425 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,782,777,600 |
| Day High |
4.0099 |
| Day Low |
4.0099 |
| Debt To Equity |
4.885 |
| Earnings Call Timestamp End |
1,741,345,140 |
| Earnings Call Timestamp Start |
1,741,345,140 |
| Earnings Timestamp End |
1,773,345,600 |
| Earnings Timestamp Start |
1,773,345,600 |
| Ebitda |
-51,890,000 |
| Ebitda Margins |
0.0 |
| Enterprise To Ebitda |
-1.445 |
| Enterprise Value |
74,992,016 |
| Eps Current Year |
-1.42 |
| Eps Forward |
-0.25862262 |
| Eps Trailing Twelve Months |
-1.92 |
| Esg Populated |
0 |
| Exchange |
NMS |
| Exchange Data Delayed By |
0 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fax |
41 44 755 77 07 |
| Fifty Day Average |
3.98146 |
| Fifty Day Average Change |
0.028439999 |
| Fifty Day Average Change Percent |
0.0071431077 |
| Fifty Two Week Change Percent |
12.324929 |
| Fifty Two Week High |
5.36 |
| Fifty Two Week High Change |
-1.3501 |
| Fifty Two Week High Change Percent |
-0.25188434 |
| Fifty Two Week Low |
3.41 |
| Fifty Two Week Low Change |
0.5999 |
| Fifty Two Week Low Change Percent |
0.17592375 |
| Fifty Two Week Range |
3.41 - 5.36 |
| Financial Currency |
CHF |
| First Trade Date Milliseconds |
1,623,850,200,000 |
| Float Shares |
19,918,428 |
| Forward Eps |
-0.25862262 |
| Forward P E |
-15.504831 |
| Free Cashflow |
-25,200,500 |
| Full Exchange Name |
NasdaqGS |
| Full Time Employees |
134 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Gross Margins |
0.0 |
| Gross Profits |
-36,662,000 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.0 |
| Held Percent Institutions |
0.095769994 |
| Implied Shares Outstanding |
37,511,163 |
| Industry |
Biotechnology |
| Industry Disp |
Biotechnology |
| Industry Key |
biotechnology |
| Ipo Expected Date |
2,021-06-16 |
| Is Earnings Date Estimate |
0 |
| Language |
en-US |
| Last Fiscal Year End |
1,767,139,200 |
| Long Business Summary |
Molecular Partners AG, a clinical-stage biotechnology company, designs and develops designed ankyrin repeat proteins therapeutics for the treatment of oncology diseases in Switzerland. Its product pipeline comprises MP0317, which is in Phase 2 clinical trial for the treatment of advanced solid tumors; MP053, novel tetra-specific T cell-engaging DARPin, which is phase 1 clinical trial for the treatment of acute myeloid leukemia; and MP0712, a 212Pb Radio-DARPin therapy (RDT) candidate targeting the tumor-associated protein delta-like ligand 3 (DLL3) which is in Phase 1 clinical trial to treat SCLC and neuroendocrine tumors. It also researches for Switch-DARPin T cell engager to treat CD3 x costim x; and MP0726, a Radio-DARPin Therapy to treat ovarian cancer and other MSLNexpressing cancers. In addition, the company develops MP0621, a Switch-DARPin candidate targeting CD16a, c-KIT, and CD47 as conditioning for hematopoietic stem cell transplantation; and Radio-DARPin Therapy (RDT) platform, a delivery system for effective and selective delivery of radioactive payloads to solid tumors. It has collaboration agreement with Orano Med SAS to develop novel Radio-DARPin therapeutics and an additional six targeted alpha therapeutics candidates and Eckert & Ziegler SE to develop Radio-DARPin therapeutics. Molecular Partners AG was incorporated in 2004 and is headquartered in Schlieren, Switzerland. |
| Long Name |
Molecular Partners AG |
| Market |
us_market |
| Market Cap |
150,416,016 |
| Market State |
REGULAR |
| Max Age |
86,400 |
| Message Board Id |
finmb_32677064 |
| Most Recent Quarter |
1,774,915,200 |
| Net Income To Common |
-58,024,000 |
| Next Fiscal Year End |
1,798,675,200 |
| Non Diluted Market Cap |
147,402,530 |
| Number Of Analyst Opinions |
5 |
| Open |
3.9 |
| Operating Cashflow |
-48,420,000 |
| Operating Margins |
0.0 |
| Payout Ratio |
0.0 |
| Phone |
41 44 755 77 00 |
| Previous Close |
4.0099 |
| Price Eps Current Year |
-2.8238733 |
| Price Hint |
4 |
| Price To Book |
1.7757922 |
| Profit Margins |
0.0 |
| Quick Ratio |
9.215 |
| Quote Source Name |
Delayed Quote |
| Quote Type |
EQUITY |
| Recommendation Key |
strong_buy |
| Recommendation Mean |
1.4 |
| Region |
US |
| Regular Market Change |
0.0 |
| Regular Market Change Percent |
0.0 |
| Regular Market Day High |
4.0099 |
| Regular Market Day Low |
4.0099 |
| Regular Market Day Range |
4.0099 - 4.0099 |
| Regular Market Open |
3.9 |
| Regular Market Previous Close |
4.0099 |
| Regular Market Price |
4.0099 |
| Regular Market Time |
1,783,972,800 |
| Regular Market Volume |
74 |
| Return On Assets |
-0.28816998 |
| Return On Equity |
-0.59014 |
| Sand P52 Week Change |
0.20365608 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Shares Outstanding |
37,511,163 |
| Shares Percent Shares Out |
0.0 |
| Shares Short |
1,751 |
| Shares Short Previous Month Date |
1,780,012,800 |
| Shares Short Prior Month |
10,189 |
| Short Name |
Molecular Partners AG |
| Short Percent Of Float |
0.0001 |
| Short Ratio |
0.24 |
| Source Interval |
15 |
| Symbol |
MOLN |
| Target High Price |
16.986532 |
| Target Low Price |
3.6636891 |
| Target Mean Price |
11.056733 |
| Target Median Price |
11.945088 |
| Total Cash |
78,768,000 |
| Total Cash Per Share |
2.1 |
| Total Debt |
3,344,000 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
0.0 |
| Trailing Annual Dividend Yield |
0.0 |
| Trailing Eps |
-1.92 |
| Trailing Peg Ratio |
None |
| Triggerable |
1 |
| Two Hundred Day Average |
4.18452 |
| Two Hundred Day Average Change |
-0.17461967 |
| Two Hundred Day Average Change Percent |
-0.04172992 |
| Type Disp |
Equity |
| Volume |
74 |
| Website |
https://www.molecularpartners.com |
| Zip |
8,952 |